California State University evaluates the feasibility and acceptability of "PrEP-Talk"
Photo by Marquise Kamanke
California State University, Dominguez Hills is conducting the clinical trial PrEP Talk: PrEP Uptake With Young Black MSM and Their Close Friends (PrEP-Talk).
Young Black MSM (YBMSM) are at critically high and disproportionate HIV risk. Reducing HIV incidence rates among YBMSM will likely require increased adoption of additional strategies such as pre-exposure prophylaxis (PrEP). PrEP is a FDA approved medication for HIV that also prevents HIV transmission when taken appropriately. Interventions are needed to address potential individual, social/cultural, and structural barriers to uptake and adherence of PrEP among YBMSM to help curb HIV infections.
The researchers propose "PrEP-Talk", an intervention that will use a PrEP Counselor (PC) who can provide information and guidance to YBMSM as they weigh their options regarding HIV risk along with the inclusion of a close friend (CF) to support PrEP uptake and adherence.
It is planned to include 120 participants.
Actual study start date is September 1, 2020. The researchers expect to complete the study by December 31, 2024.
The decision to Begin PrEP is the primary outcome measure.
The location of the study is as follows (further details can be found here https://ichgcp.net/clinical-trials-registry/NCT04601649) Los Angeles, United States.
